KemPharm, Inc. (KMPH) Financials

NASDAQ Currency in USD Disclaimer

$5.81

north_east NA Past Year
Day's range
$5.79
Day's range
$5.97
$40M$40M$20M$20M$0$0-$20M-$20M-$40M-$40M-$60M-$60MEarning201620162017201720182018201920192020202020212021202220220%0%-100%-100%-200%-200%-300%-300%-400%-400%-500%-500%Profit Margin
Profit Margin
Revenue
Earnings

KMPH Income statement / Annual

Last year (2022), KemPharm, Inc.'s total revenue was $10.46 M, a decrease of 63.50% from the previous year. In 2022, KemPharm, Inc.'s net income was -$41.54 M. See KemPharm, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014 FY-2013
Period Ended 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013
Operating Revenue $10.46 M $28.65 M $13.29 M $12.84 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $343,000.00 $2.06 M $1.31 M $2.95 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $10.12 M $26.59 M $11.98 M $9.89 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit Ratio 0.97 0.93 0.9 0.77 0 0 0 0 0 0
Research and Development Expenses $19.61 M $10.16 M $8.84 M $19.42 M $41.76 M $20.59 M $20.47 M $13.93 M $11.92 M $3.37 M
General & Administrative Expenses $15.34 M $8.70 M $7.92 M $10.82 M $12.51 M $12.77 M $17.01 M $8.88 M $0.00 $1.35 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $15.34 M $8.70 M $7.92 M $10.82 M $12.51 M $12.77 M $17.01 M $8.88 M $0.00 $1.35 M
Other Expenses $17.66 M $2.06 M $2.13 M $2.95 M $1.64 M $0.00 $3.01 M $0.00 -$28.36 M $0.00
Operating Expenses $34.96 M $18.86 M $16.76 M $30.23 M $54.27 M $33.37 M $37.48 M $22.81 M -$16.44 M $4.72 M
Cost And Expenses $35.30 M $20.92 M $18.07 M $33.18 M $54.27 M $33.37 M $37.48 M $22.81 M $16.44 M $4.72 M
Interest Income $760,000.00 $248,000.00 $89,000.00 $309,000.00 $420,000.00 $365,000.00 $353,000.00 $32,000.00 $4,283.00 $52,000.00
Interest Expense $335,000.00 $376,000.00 $7.09 M $6.51 M $7.09 M $7.34 M $7.13 M $2.67 M $2.72 M $157,000.00
Depreciation & Amortization $760,000.00 $248,000.00 $89,000.00 $309,000.00 $324,000.00 $336,000.00 $175,000.00 $84,000.00 $74,763.00 $68,000.00
EBITDA -$24.08 M $7.98 M -$4.69 M -$20.03 M -$49.18 M -$35.76 M -$9.23 M -$51.88 M -$21.69 M -$5.02 M
EBITDA Ratio -2.3 0.28 -0.35 -1.56 0 0 0 0 0 0
Operating Income Ratio -2.38 0.27 -0.36 -1.58 0 0 0 0 0 0
Total Other Income/Expenses Net -$17.49 M -$16.25 M -$7.19 M -$4.21 M -$689,000.00 -$10.06 M $20.95 M -$31.82 M -$8.03 M -$528,000.00
Income Before Tax -$42.33 M -$8.52 M -$12.79 M -$24.54 M -$56.59 M -$43.43 M -$16.53 M -$54.64 M -$24.48 M -$5.25 M
Income Before Tax Ratio -4.05 -0.3 -0.96 -1.91 0 0 0 0 0 0
Income Tax Expense -$786,000.00 $34,000.00 -$34,000.00 -$22,000.00 -$126,000.00 -$43,000.00 -$15,000.00 $26,000.00 -$22,247.00 -$20,000.00
Net Income -$41.54 M -$8.56 M -$12.76 M -$24.52 M -$56.47 M -$43.39 M -$16.52 M -$54.66 M -$24.45 M -$5.23 M
Net Income Ratio -3.97 -0.3 -0.96 -1.91 0 0 0 0 0 0
EPS -1.2 -0.29 -3.21 -13.23 -50.39 -47.37 -18.1 -118.69 -50.01 -10.69
EPS Diluted -1.2 -0.29 -3.21 -13.23 -50.39 -47.37 -18.1 -118.69 -50.01 -10.69
Weighted Average Shares Out $34.49 M $29.77 M $3.98 M $1.85 M $1.12 M $915,806.00 $912,315.00 $460,542.00 $488,959.00 $488,959.00
Weighted Average Shares Out Diluted $34.49 M $29.77 M $3.98 M $1.85 M $1.12 M $915,806.00 $912,315.00 $460,542.00 $488,959.00 $488,959.00
Link